LYTTON LAURENCE W 13D/13G Filings for Aytu BioPharma, Inc. (AYTU)

LYTTON LAURENCE W 13D and 13G filings for Aytu BioPharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-06-13
2:09 pm
Purchase
2025-06-09 13G Aytu BioPharma, Inc.
AYTU
LYTTON LAURENCE W 506,605
5.600%
506,605increase
(New Position)
Filing